Your browser doesn't support javascript.
loading
Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis.
Kapoor, Sabrina R; Filer, Andrew; Fitzpatrick, Martin A; Fisher, Benjamin A; Taylor, Peter C; Buckley, Christopher D; McInnes, Iain B; Raza, Karim; Young, Stephen P.
Affiliation
  • Kapoor SR; University of Birmingham and the Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
Arthritis Rheum ; 65(6): 1448-56, 2013 Jun.
Article in En | MEDLINE | ID: mdl-23460124
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Immunoglobulin G / Tumor Necrosis Factor-alpha / Receptors, Tumor Necrosis Factor / Antirheumatic Agents / Metabolome / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Arthritis Rheum Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Immunoglobulin G / Tumor Necrosis Factor-alpha / Receptors, Tumor Necrosis Factor / Antirheumatic Agents / Metabolome / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Arthritis Rheum Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: United States